Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 21, 2026; 32(47): 122108
Published online Dec 21, 2026. doi: 10.3748/wjg.122108
Published online Dec 21, 2026. doi: 10.3748/wjg.122108
Table 2 Levels of study variables
| Variables | mean ± SD |
| QoL | 175.48 ± 33.02 |
| Bowel symptoms | 57.70 ± 10.71 |
| Systemic symptoms | 25.15 ± 5.54 |
| Emotional function | 64.90 ± 12.18 |
| Social function | 27.73 ± 7.41 |
| Sleep | 7.15 ± 4.22 |
| Subjective sleep quality | 1.15 ± 0.82 |
| Sleep latency | 1.34 ± 0.98 |
| Sleep duration | 1.11 ± 0.91 |
| Habitual sleep efficiency | 0.77 ± 1.05 |
| Sleep disturbances | 1.29 ± 0.58 |
| Use of sleeping medication | 0.43 ± 0.95 |
| Daytime dysfunction | 1.06 ± 1.00 |
| Treatment burden | 39.81 ± 30.54 |
| Medication burden | 8.05 ± 8.26 |
| Medical visits and follow-up | 13.79 ± 11.53 |
| Medical-related behaviors and lifestyle | 15.49 ± 11.42 |
| Health problems | 2.47 ± 2.56 |
- Citation: Wang XR, Zhang N, Li B, Zhang QM, Li MR, Ma HW. Sleep quality, treatment burden, and quality of life in patients with inflammatory bowel disease: A cross-sectional study. World J Gastroenterol 2026; 32(47): 122108
- URL: https://www.wjgnet.com/1007-9327/full/v32/i47/122108.htm
- DOI: https://dx.doi.org/10.3748/wjg.122108